Skip to main content
Livermore
Livermore
ZHEN

Invesco Ltd.

SEC CIK
0000914208
Latest filing
Aug 14, 2026

RXRX holding history

Recursion Pharmaceuticals, Inc. in every 13F filed by Invesco Ltd., including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.

RXRX overviewAll 13F holders of RXRXFull Q2 2026 holdings

Shares (Q2 2026)
795,698
Value
$2.92M
% of portfolio
<0.1%
Quarters held
20
Since Q2 2021
Holdings of RXRX by Invesco Ltd., by quarter
QuarterSharesValue% of portfolioShare changeActionAll holders
Q2 2026795,698$2.92M<0.1%+104,545+15.1%AddedHolders
Q1 2026691,153$2.12M<0.1%+165,009+31.4%AddedHolders
Q4 2025526,144$2.15M<0.1%+107,979+25.8%AddedHolders
Q3 2025418,165$2.04M<0.1%+99,053+31.0%AddedHolders
Q2 2025319,112$1.61M<0.1%+116,581+57.6%AddedHolders
Q1 2025202,531$1.07M<0.1%+23,912+13.4%AddedHolders
Q4 2024178,619$1.21M<0.1%+63,068+54.6%AddedHolders
Q3 2024115,551$761.5K<0.1%+7,284+6.7%AddedHolders
Q2 2024108,267$812.0K<0.1%+9,703+9.8%AddedHolders
Q1 202498,564$982.7K<0.1%−22,322−18.5%ReducedHolders
Q4 2023120,886$1.19M<0.1%+13,796+12.9%AddedHolders
Q3 2023107,090$819.2K<0.1%+580+0.5%AddedHolders
Q2 2023106,510$795.6K<0.1%−12,705−10.7%ReducedHolders
Q1 2023119,215$795.2K<0.1%+74,595+167.2%AddedHolders
Q4 202244,620$344.0K<0.1%−332−0.7%ReducedHolders
Q3 202244,952$478.0K<0.1%+669+1.5%AddedHolders
Q2 202244,283$361.0K<0.1%−350−0.8%ReducedHolders
Q1 202244,633$320.0K<0.1%+1,160+2.7%AddedHolders
Q4 202143,473$745.0K<0.1%+43,473NewHolders
Q3 20210$00.0%−5,612−100.0%Sold outHolders
Q2 20215,612$205.0K<0.1%+5,612NewHolders